Metraipolis › archive › dc_b436327172e2

Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label,… — Europe PMC PMID:41014973

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41014973
DOI
10.1016/j.ebiom.2025.105929
License (as archived)
solo-consultazione
Archived
2026-11-09T18:05:53.541Z
SHA-256 of the archived text
590e66afa49e42a7417e15f408d5e0ef763ab17e581966b82dfeb295b45b585f
Stable URL of this page
https://metraipolis.com/documento/dc_b436327172e2

How to cite

Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label,… — Europe PMC PMID:41014973 — Europe PMC (en), https://europepmc.org/article/MED/41014973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b436327172e2 (Metraipolis archive dc_b436327172e2, sha256 590e66afa49e42a7417e15f408d5e0ef763ab17e581966b82dfeb295b45b585f)
BibTeX
@misc{dcb436327172e2,
  title = {Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label,… — Europe PMC PMID:41014973},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41014973},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b436327172e2; sha256 590e66afa49e42a7417e15f408d5e0ef763ab17e581966b82dfeb295b45b585f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41014973. Agents can read the archived copy with the MCP tool read_document.